On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Financial Results for Full-Year 2019

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today released financial results for its full year ended December 31, 2019, as well as select corporate highlights. Among the highlights, the company reported its securing of a $15.0 million equity line with Oasis Capital, LLC, … Continue reading “NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Financial Results for Full-Year 2019”

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Helomics’ Continued Progress Toward Developing AI-Driven Predictive Model of Ovarian Cancer

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced continued progress by its Helomics subsidiary toward the goal of developing an AI-driven predictive model of ovarian cancer (CancerQuest 2020). Per the update, CancerQuest2020 (CCQ2020) is focused on building an AI-driven model of ovarian … Continue reading “NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Helomics’ Continued Progress Toward Developing AI-Driven Predictive Model of Ovarian Cancer”

Predictive Oncology Inc. (NASDAQ: POAI) Enters into Securities Purchase Agreement to Raise $3.5 Million

POAI announces securities purchase agreement with accredited investors to purchase shares of common stock Company to use net proceeds from purchase agreement for general corporate purposes Agreement expected to raise $3.5 million through issuance of up to 1,650,165 shares of common stock or common stock equivalents Predictive Oncology Inc. (NASDAQ: POAI), a leader in the cancer precision-medicine … Continue reading “Predictive Oncology Inc. (NASDAQ: POAI) Enters into Securities Purchase Agreement to Raise $3.5 Million”

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Secures $3.5 Million in Private Placement

Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced its March 19, 2020, closing on its previously announced private offering of common stock and warrants resulting in gross proceeds of $3,498,612 to the Company. … Continue reading “NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Secures $3.5 Million in Private Placement”

AI Accelerates Vaccine Development; Predictive Oncology Inc. (NASDAQ: POAI) Launches AI Platform to Battle Coronaviruses, Acute Respiratory Syndromes

Artificial Intelligence at the forefront of scientific discovery, proving importance in complex diseases Predictive Oncology launches new AI platform in fight against new pathogens Artificial intelligence likely to help find COVID-19 vaccines and therapeutics With the global onslaught of COVID-19, scientists are turning to the speed and power of artificial intelligence to find solutions. The … Continue reading “AI Accelerates Vaccine Development; Predictive Oncology Inc. (NASDAQ: POAI) Launches AI Platform to Battle Coronaviruses, Acute Respiratory Syndromes”

Predictive Oncology Inc.’s (NASDAQ: POAI) AI Solutions to Combat Cancer, Similar Technological Solutions Called Upon to Fight COVID-19

Artificial intelligence (AI) at forefront of scientific discovery, proving importance in fighting complex diseases Science turns to AI as effective tool to help find COVID-19 vaccines and therapeutics Predictive Oncology harnesses power of AI to improve cancer patient outcomes With the global onslaught of COVID-19, scientists are harnessing the speed and power of artificial intelligence … Continue reading “Predictive Oncology Inc.’s (NASDAQ: POAI) AI Solutions to Combat Cancer, Similar Technological Solutions Called Upon to Fight COVID-19”

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters Securities Purchase Agreement to Raise $3.5M through Private Placement

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, this morning announced its entrance into a securities purchase agreement with certain accredited investors to raise $3.5 million through the issuance of up to 1,650,165 shares of common stock or common stock equivalents and accompanying warrants … Continue reading “NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters Securities Purchase Agreement to Raise $3.5M through Private Placement”

Predictive Oncology Inc. (NASDAQ: POAI) AI/ML Expertise, Recent Acquisition Invaluable Resources in Search for New Anti-Virals, Vaccines

POAI positioned as leader in using data, artificial intelligence in search for novel effective treatments Planned acquisition provides Predictive Oncology with CoRE(TM), a proven machine-learning framework Uniting CoRE with proprietary PDx tumor-profiling platform and tumor-data database creates one-of-a-kind, end-to-end “discovery machine” With its recent proposed acquisition of Carnegie Mellon spin-out Quantitative Medicine, Predictive Oncology Inc. … Continue reading “Predictive Oncology Inc. (NASDAQ: POAI) AI/ML Expertise, Recent Acquisition Invaluable Resources in Search for New Anti-Virals, Vaccines”

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Launch of New AI Platform for Vaccine and Drug Development Targeting COVID-19, MERS and SARS

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its plans to launch a new AI platform for vaccine and drug development targeting Coronaviruses and Acute Respiratory Syndromes (COVID-19, MERS and SARS) through an operating agreement with Soluble Therapeutics.  According to the update, … Continue reading “NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Launch of New AI Platform for Vaccine and Drug Development Targeting COVID-19, MERS and SARS”

Predictive Oncology Inc. (NASDAQ: POAI) Appoints New Board Member with Impressive CSO, Senior Research Background

Dan Handley brings wealth of invaluable experience to POAI’s board of directors Newest board member has extensive experience with entities closely associated with POAI’s Helomics division Predictive Oncology set to benefit from Handley’s broad knowledge, expertise Predictive Oncology Inc. (NASDAQ: POAI), a leader in the cancer precision-medicine field, has announced the unanimous appointment of its … Continue reading “Predictive Oncology Inc. (NASDAQ: POAI) Appoints New Board Member with Impressive CSO, Senior Research Background”

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217